Source: Orphanet Journal of Rare Diseases. Unidade: FM
Subjects: CATETERISMO CARDÍACO, ECOCARDIOGRAFIA, PREVALÊNCIA, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Carolina S. G. et al. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method. Orphanet Journal of Rare Diseases, v. 12, p. 7 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s13023-017-0626-0. Acesso em: 02 jul. 2024.APA
Freitas, C. S. G., Baldi, B. G., Jardim, C., Araujo, M. S., Sobral, J. B., Heiden, G. I., et al. (2017). Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method. Orphanet Journal of Rare Diseases, 12, 7 . doi:10.1186/s13023-017-0626-0NLM
Freitas CSG, Baldi BG, Jardim C, Araujo MS, Sobral JB, Heiden GI, Kairalla RA, Souza R, Carvalho CRR. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method [Internet]. Orphanet Journal of Rare Diseases. 2017 ; 12 7 .[citado 2024 jul. 02 ] Available from: https://doi.org/10.1186/s13023-017-0626-0Vancouver
Freitas CSG, Baldi BG, Jardim C, Araujo MS, Sobral JB, Heiden GI, Kairalla RA, Souza R, Carvalho CRR. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method [Internet]. Orphanet Journal of Rare Diseases. 2017 ; 12 7 .[citado 2024 jul. 02 ] Available from: https://doi.org/10.1186/s13023-017-0626-0
